...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: What's going on with the Phase 2 ZEN-3694 mCRPC trial?
Reply New Message
Back To Forum List View
Icon president What's going on with the Phase 2 ZEN-3694 mCRPC trial?
6
BearDownAZ
Jul 20, 2019 08:39AM
Re: What's going on with the Phase 2 ZEN-3694 mCRPC trial?
5
tada
Jul 22, 2019 09:19AM
Icon president Re: What's going on with the Phase 2 ZEN-3694 mCRPC trial?
6
BearDownAZ
Jul 22, 2019 10:17AM
Re: What's going on with the Phase 2 ZEN-3694 mCRPC trial?
2
noretreat
Jul 24, 2019 06:52PM
Icon president Re: What's going on with the Phase 2 ZEN-3694 mCRPC trial?
5
BearDownAZ
Jul 25, 2019 02:50PM
Re: What's going on with the Phase 2 ZEN-3694 mCRPC trial?
3
Nextblockbuster
Jul 25, 2019 03:22PM
Re: What's going on with the Phase 2 ZEN-3694 mCRPC trial?
6
fouremm
Jul 26, 2019 12:44AM
Re: What's going on with the Phase 2 ZEN-3694 mCRPC trial?
4
Nextblockbuster
Jul 26, 2019 10:50AM
Re: What's going on with the Phase 2 ZEN-3694 mCRPC trial?
3
Toinv
Jul 26, 2019 02:59PM
Re: What's going on with the Phase 2 ZEN-3694 mCRPC trial?
3
Toinv
Jul 26, 2019 03:07PM

Based on the Feb 2019 presentation the bleed rate is $2mm/qtr or approx $700m/month so this funding seems to provide 3+ months of funding. I'm not sure if the Feb presentation includes the TNBC trial costs. Good to get the money but seems like they need much more.

Toinv

3 Recommendations
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply